Mitsis, T., Efthimiadou, A., Bacopoulou, F., Vlachakis, D., Chrousos, G. P., & Eliopoulos, E. (2020). Transcription factors and evolution: An integral part of gene expression (Review). World Acad Sci J, 2, 3–8. https://doi.org/10.3892/wasj.2020.32

Article  Google Scholar 

Papantonis, A., & Cook, P. R. (2013). Transcription factories: Genome organization and gene regulation. Chemical Reviews, 113, 8683–8705. https://doi.org/10.1021/cr300513p

Article  CAS  PubMed  Google Scholar 

Ecker, S., Pancaldi, V., Valencia, A., Beck, S., & Paul, D. S. (2018). Epigenetic and Transcriptional Variability Shape Phenotypic Plasticity. Bioessays, 40, 1700148. https://doi.org/10.1002/bies.201700148

Article  CAS  Google Scholar 

Vogt, G. (2022). Epigenetics and Phenotypic Plasticity in Animals. Epigenetics, Development, Ecology and Evolution. 35–108 https://doi.org/10.1007/978-3-031-13771-6_3

Jin, Y., Liu, T., Luo, H., Liu, Y., & Liu, D. (2022). Targeting Epigenetic Regulatory Enzymes for Cancer Therapeutics: Novel Small-Molecule Epidrug Development. Frontiers In Oncology, 12, 848221. https://doi.org/10.3389/fonc.2022.848221

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nozaki, T., & Kanai, M. (2021). Chemical Catalysis Intervening to Histone Epigenetics. Accounts Of Chemical Research, 54, 2313–2322. https://doi.org/10.1021/acs.accounts.1c00144

Article  CAS  PubMed  Google Scholar 

Smirnova, L., Sittka, A., & Luch, A. (2012). On the Role of Low-Dose Effects and Epigenetics in Toxicology. EXS, 101, 499–550. https://doi.org/10.1007/978-3-7643-8340-4_18

Article  PubMed  Google Scholar 

Issuree, P. D. A., Ng, C. P., & Littman, D. R. (2017). Heritable gene regulation in the CD4: CD8 T cell lineage choice. Frontiers In Immunology, 8, 250073. https://doi.org/10.3389/fimmu.2017.00291

Article  CAS  Google Scholar 

Wang, X. W., Guo, L. Y., Han, M., & Shan, K. (2016 17:1). Diversity, evolution and expression profiles of histone acetyltransferases and deacetylases in oomycetes. BMC Genomics 17, 927- (2016). https://doi.org/10.1186/s12864-016-3285-y

Son, A., Park, J., Kim, W., Yoon, Y., Lee, S., Ji, J., & Kim, H. (2024). Recent Advances in Omics, Computational Models, and Advanced Screening Methods for Drug Safety and Efficacy. Toxics, 12, 822. https://doi.org/10.3390/toxics12110822

Article  CAS  PubMed  PubMed Central  Google Scholar 

Addis, H. G., & Carlson, E. E. (2025). Recent advances in high-throughput screening methods for small molecule modulators in bacteria. Current Opinion In Chemical Biology, 85, 102571. https://doi.org/10.1016/j.cbpa.2025.102571

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gan, L., Yang, Y., Li, Q., Feng, Y., Liu, T., & Guo, W. (2018). Epigenetic regulation of cancer progression by EZH2: From biological insights to therapeutic potential. Biomarker Research, 6, 1–10. https://doi.org/10.1186/s40364-018-0122-2

Article  Google Scholar 

Zhao, X., Nihira, N. T., Dai, X., & Liu, Z. (2024). Editorial: Community series in post-translational modifications of proteins in cancer immunity and immunotherapy, III. Frontiers In Immunology, 15. https://doi.org/10.3389/fimmu.2024.1533926

Baylin, S. B., & Jones, P. A. (2016). Epigenetic Determinants of Cancer. Cold Spring Harb. Perspect. Biol. 8, a019505 https://doi.org/10.1101/cshperspect.a019505

Kabir, M., Yu, X., Kaniskan, H. Ü., & Jin, J. (2023). Chemically induced degradation of epigenetic targets. Chemical Society Reviews, 52, 4313–4342. https://doi.org/10.1039/d3cs00100h

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bauer, A. J., & Martin, K. A. (2017). Coordinating Regulation of Gene Expression in Cardiovascular Disease: Interactions between Chromatin Modifiers and Transcription Factors. Front Cardiovasc Med, 4, 248718. https://doi.org/10.3389/fcvm.2017.00019

Article  CAS  Google Scholar 

Li, X., Egervari, G., Wang, Y., Berger, S. L., & Lu, Z. (2018). Regulation of chromatin and gene expression by metabolic enzymes and metabolites. Nature Reviews Molecular Cell Biology 2018, 19, 9. https://doi.org/10.1038/s41580-018-0029-7

Article  CAS  Google Scholar 

Declerck, K., Szarc vel Szic, K., Palagani, A., Heyninck, K., Haegeman, G., Morand, C., Milenkovic, D., & Berghe, V. (2015). Epigenetic control of cardiovascular health by nutritional polyphenols involves multiple chromatin-modifying writer-reader-eraser proteins. Current Topics In Medicinal Chemistry, 16, 788–806. https://doi.org/10.2174/1568026615666150825141720

Article  CAS  Google Scholar 

Shvedunova, M., & Akhtar, A. (2022 23:5). Modulation of cellular processes by histone and non-histone protein acetylation. Nature Reviews Molecular Cell Biology 23, 329–349 (2022). https://doi.org/10.1038/s41580-021-00441-y

O’garro, C., Igbineweka, L., Ali, Z., Mezei, M., & Mujtaba, S. (2021). The Biological Significance of Targeting Acetylation-Mediated Gene Regulation for Designing New Mechanistic Tools and Potential Therapeutics. Biomolecules, 11(3), 455. https://doi.org/10.3390/biom11030455

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bassett, S. A., & Barnett, M. P. G. (2014). The Role of Dietary Histone Deacetylases (HDACs) Inhibitors in Health and Disease. Nutrients, 6(10), 4273–4301. https://doi.org/10.3390/nu6104273

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu, J., Yu, Y., Kelly, J., Sha, D., Alhassan, A. B., Yu, W., Maletic, M. M., Duffy, J. L., Klein, D. J., Holloway, M. K., Carroll, S., Howell, B. J., Barnard, R. J. O., Wolkenberg, S., & Kozlowski, J. A. (2020). Discovery of Highly Selective and Potent HDAC3 Inhibitors Based on a 2-Substituted Benzamide Zinc Binding Group. Acs Medicinal Chemistry Letters, 11, 2476–2483. https://doi.org/10.1021/acsmedchemlett.0c00462

Article  CAS  PubMed  PubMed Central  Google Scholar 

Milazzo, G., Mercatelli, D., Di Muzio, G., Triboli, L., De Rosa, P., Perini, G., & Giorgi, F. M. (2020). Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability. Genes, 11(5), 556. https://doi.org/10.3390/genes11050556

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lemos, M., & Stefanova, N. (2020). Histone Deacetylase 6 and the Disease Mechanisms of α-Synucleinopathies. Frontiers In Synaptic Neuroscience, 12, 586453. https://doi.org/10.3389/fnsyn.2020.586453

Article  CAS  PubMed  PubMed Central  Google Scholar 

West, A. C., & Johnstone, R. W. (2014). New and emerging HDAC inhibitors for cancer treatment. J Clin Invest, 124, 30–39. https://doi.org/10.1172/jci69738

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ververis, K., Hiong, A., Karagiannis, T. C., & Licciardi, P. V. (2013). Histone deacetylase inhibitors (HDACIS): Multitargeted anticancer agents. Biologics, 7, 47–60. https://doi.org/10.2147/btt.s29965

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hawash, M. (2025). Next-Generation HDAC Inhibitors: Advancing Zinc-Binding Group Design for Enhanced Cancer Therapy. Cells 2025, 14. https://doi.org/10.3390/cells14241997

Edwards, J. R., Yarychkivska, O., Boulard, M., & Bestor, T. H. (2017). DNA methylation and DNA methyltransferases. Epigenetics Chromatin, 10, 1–10. https://doi.org/10.1186/s13072-017-0130-8

Article  CAS  Google Scholar 

Jurkowska, R. Z., & Jeltsch, A. (2022). Mechanisms and Biological Roles of DNA Methyltransferases and DNA Methylation: From Past Achievements to Future Challenges. Advances In Experimental Medicine And Biology, 1389, 1–19. https://doi.org/10.1007/978-3-031-11454-0_1

Article  CAS  PubMed  Google Scholar 

Tajima, S., Suetake, I., Takeshita, K., Nakagawa, A., Kimura, H., & Song, J. (2022). Domain Structure of the Dnmt1, Dnmt3a, and Dnmt3b DNA Methyltransferases. Advances In Experimental Medicine And Biology, 1389, 45–68. https://doi.org/10.1007/978-3-031-11454-0_3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lim, S. P., Neilsen, P., Kumar, R., Abell, A., & Callen, D. F. (2012). The Application of Delivery Systems for DNA Methyltransferase Inhibitors. BioDrugs. 2011 25(4), 227–242 https://doi.org/10.2165/11592770-000000000-00000

Chen, Q., Liu, B., Zeng, Y., Hwang, J. W., Dai, N., Correa, I. R., Estecio, M. R., Zhang, X., Santos, M. A., Chen, T., & Cheng, X. (2023). GSK-3484862 targets DNMT1 for degradation in cells. NAR Cancer, 5. https://doi.org/10.1093/narcan/zcad022

Hu, C., Liu, X., Zeng, Y., Liu, J., & Wu, F. (2021). DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application. Clinical Epigenetics 2021, 13, 1. https://doi.org/10.1186/s13148-021-01154-x

Article  CAS  Google Scholar 

Casciello, F., Windloch, K., Gannon, F., & Lee, J. S. (2015). Functional role of G9a histone methyltransferase in cancer. Frontiers In Immunology, 6, 156818. https://doi.org/10.3389/fimmu.2015.00487